Immunosuppressive strategies in transplantation
- 1 March 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 353 (9158) , 1083-1091
- https://doi.org/10.1016/s0140-6736(98)07493-5
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL TRANSPLANT RECIPIENTSTransplantation, 1998
- TacrolimusDrugs, 1997
- A RANDOMIZED MULTICENTER TRIAL COMPARING LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 MONOCLONAL ANTIBODY WITH RABBIT ANTITHYMOCYTE GLOBULIN AS INDUCTION TREATMENT IN FIRST KIDNEY TRANSPLANTATIONSTransplantation, 1996
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.Journal of Clinical Investigation, 1996
- The role of CD40 in the regulation of humoral and cell-mediated immunityImmunology Today, 1994
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- T-Lymphocyte-Antigen Interactions in Transplant RejectionNew England Journal of Medicine, 1990
- CyclosporineNew England Journal of Medicine, 1989